AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery

RecruitingNAAges 18 Years - 75 YearsAllThe First Affiliated Hospital with Nanjing Medica…
💬

In plain words

What the trial is, and whether it could suit you

\*\*Research Background\*\* Colostomy surgery is a common surgical procedure widely used for the treatment of various gastrointestinal diseases, including rectal cancer, ulcerative colitis, and Crohn's disease. Although this surgery can significantly improve patients' quality of life and prognosis, the incidence of postoperative complications, particularly parastomal hernia (PSH), is relatively high. PSH refers to the formation of an abdominal wall hernia around the stoma, with an incidence rate that can reach up to 50%. PSH not only affects patients' quality of life but can also lead to pain, stoma dysfunction, and the need for reoperation, increasing medical costs and patient burden. Therefore, how to effectively prevent PSH has become an important topic in clinical research. \*\*Epidemiology of Parastomal Hernia\*\* The incidence of PSH varies across different studies, ranging from

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older. * Patients requiring colostomy surgery. * Ability to provide written informed consent. * Expected survival of more than one year. * No severe comorbidities such as heart, lung, liver, or kidney dysfunction. Exclusion Criteria: * Pregnant or breastfeeding women. * History of major abdominal surgery that could affect the development of PSH. * Mental illness that impairs understanding of the study content and ability to give informed consent. * Patients receiving immunosuppressive therapy or chemotherapy.
💊

What it tests

  • Regular
  • Mesenteric Molding Suturing Group
📍

Where

1 site
First Affiliated Hospital of Nanjing Medical University
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy